Gregory Stock
This article's use of external links may not follow Wikipedia's policies or guidelines. (June 2019) |
This biographical article is written encyclopedic . (December 2021) |
Gregory Stock is an American
Life, written works, and business career
Education
He received an MBA from Harvard Business School in 1987, where he was a Baker Scholar and won the Freund-Porter Entrepreneurship award. Stock completed a doctorate in biophysics from Johns Hopkins University in 1977, where he received a BS and MS in 1971.[1]
Biotechnology and its impact on society
He has written extensively on the implications for society, medicine and business of the
Biotech entrepreneur
Stock was the CEO of
He sits on the editorial board of the
Dr. Stock has been an invited speaker to many academic, government and business conferences. He makes regular appearances on television and radio, and has appeared on
Public policy and activities
Stock was an early force in considering the implications of
Stock is now primarily engaged in the development of new therapeutics at
Stock's expertise in biotechnology, genetics and public policy in the life sciences led to his appointment on the California Advisory Committee on Stem Cells and Reproductive Cloning, Dept. of Health Services,
Debates
Stock has always been a strong advocate for the aggressive implementation of new technology in the life sciences and he has publicly debated many leading figures in the bioethics community, including Francis Fukuyama, Jeremy Rifkin, Leon Kass,[14] George Annas, Dan Callahan,[15] Bill McKibben,[16] Michael Sandel,[17] William Hurlbut and Nigel Cameron.[18] In these appearances, he has consistently argued against restrictions on life science research including funding bans on stem cell research, moratoriums on cloning, overly protective pharmaceutical regulatory controls, and efforts to constrain anti-aging research. A fellow of the World Technology Council and World Academy of Art and Science, Stock's argues in favor of the positive benefits of new technology has on human life and the role it will play on our future.
Books
Dr. Stock has written works on the impact and significance of recent advances in technology and the life sciences, and several bestsellers on values and ethics. His Book of Questions series, which consists of four eclectic collections of provocative situational dilemmas, was designed to generate discussion and thought about value-laden issues. The series has sold more than three million copies in total, been translated into 17 languages, and spawned a host of imitations. The original Book of Questions was number 1 on the New York Times Bestseller's list for 8 weeks.
His books on technology, public policy and future human evolution are:
- Metaman:The Merging of Humans and Machines into a Global Superorganism.(1993).
- Engineering the Human Germline: An Exploration of the Science and Ethics of Altering the Genes We Pass to Our Children (2000, Oxford University Press) (Co-editor with John Campbell).
- Redesigning Humans: Our Inevitable Genetic Future (2002)Redesigning Humans won the Kistler Award Kistler Prize for science writing. Stock has also written numerous articles and papers on these topics.
- The Book of Questions (1987) ISBN 978-0-89480-320-8 [1]
- Business, Politics, and Ethics: The Book of Questions (1991, Workman. NY.)
- Love and Sex: The Book of Questions. (1989, Workman. NY.)
- The Kids' Book of Questions. (1988, Workman. NY.)
Stock currently serves on the editorial Board of Rejuvination Science, the International Journal of Bioethics,
Boards
- Board of Directors, Signum Biosciences Inc.[22]
- Board of Directors, Napo Pharmaceuticals Inc[23]
Selected articles
- Full List Available on Ucla Website
- Germinal Choice Technology and the Future of Human Reproduction - BioMedicine Online (March 2005)
- ‘Redesigning Humans’: Taking Charge of Our Own Heredity, review - The Lancet (April 2002)
- ‘Redesigning Humans’: Taking Charge of Our Own Heredity review - New York Times(August 25, 2002)
- EMBO Reports - EMBO (2002)
- Talking Stock - Spiked (June 25, 2002)
- Profile - Wall Street Journal(June 13, 2002)
- GENETIC ENGINEERING:Toward a New Human Species? review - Science(June 2002)
- Our shiny happy clone future - Salon.com (April 2002)
- Bio-Luddites square up to friends of Frankenstein - The Times Higher Education Supplement(May 17, 2002)
- Homo perfectus - Los Angeles Times Review of Books (Sunday, May 5, 2002)
- Visions of the future - Chicago Tribune (May 2002)
- The Remastered Race - Wired (April 2002)
- Cloning Research Commentary - Los Angeles Times (December 2, 2001)
- Human Germline Engineering:Best Hope or Worst Fear? Germline
References
- ^ UCLA Website: Gregory Stock Archived 2008-08-21 at the Wayback Machine
- ^ The Storefront Genome Archived 2010-07-06 at the Wayback Machine
- PMID 14659040.
- ^ Signum Biosciences Archived 2009-03-21 at the Wayback Machine
- ^ UCLA Center for Society and Genetics Archived 2009-04-18 at the Wayback Machine
- ^ Napo Pharmaceuticals Archived 2011-02-15 at the Wayback Machine
- ^ "August 17, 2007 ~ Gregory Stock | August 17, 2007 | Religion & Ethics NewsWeekly | PBS". Religion & Ethics NewsWeekly. 2007-08-17. Retrieved 2018-03-23.
- ^ Gregory Stock on Charlie Rose Archived 2012-02-21 at the Wayback Machine
- ^ Gina Kolata for the New York Times. March 21, 1998 Scientists Brace for Changes In Path of Human Evolution
- ^ Alliance for Aging Research Archived 2008-11-26 at the Wayback Machine
- ^ "BioAgenda". www.bioagendaprograms.com. Retrieved 2018-03-23.
- ^ Engineering the Human Germline Symposium Archived 2008-05-13 at the Wayback Machine
- ^ "Human Stem Cell Research Advisory Committee Information". Archived from the original on 2009-05-28. Retrieved 2009-05-01.
- ^ "Biotechnology". NPR.org. Retrieved 2018-03-23.
- ^ Edmonton Aging Symposium Presentation
- ^ "New website features live webcast with Dr. Gregory Stock and Bill McKibben". www.scienceblog.com. Retrieved 2018-03-23.
- ^ "Resources -- Articles". humanitas.org. Retrieved 2018-03-23.
- ^ The BioAgenda 2007 Great Debate: Should the world permanently ban the genetic manipulation of human embryos – yes or no?
- ^ "Ethics & Medicine – International Journal of Bioethics". www.ethicsandmedicine.com. Retrieved 2018-03-23.
- ^ "JET Editorial Board". www.jetpress.org. Retrieved 2018-03-23.
- ^ "Journal Backs Verification of Cloning Work in Wake of Scandal | Bioethics.net". www.bioethics.net. Retrieved 2018-03-23.
- ^ Signum Biosciences Inc Board of Directors Archived 2009-03-22 at the Wayback Machine
- ^ Napo Pharmaceuticals Board of Directors Archived 2011-02-15 at the Wayback Machine